BioNTech SE Statistics

Total Valuation

BioNTech SE has a market cap or net worth of $23.07 billion. The enterprise value is $7.61 billion.

Market Cap	23.07B
Enterprise Value	7.61B

Important Dates

The next estimated earnings date is Monday, August 3, 2026, before market open.

Earnings Date	Aug 3, 2026
Ex-Dividend Date	n/a

Share Statistics

BioNTech SE has 252.88 million shares outstanding. The number of shares has increased by 1.91% in one year.

Current Share Class	n/a
Shares Outstanding	252.88M
Shares Change (YoY)	+1.91%
Shares Change (QoQ)	+3.81%
Owned by Insiders (%)	16.25%
Owned by Institutions (%)	20.13%
Float	110.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.13
Forward PS	10.61
PB Ratio	1.07
P/TBV Ratio	1.19
P/FCF Ratio	32.00
P/OCF Ratio	24.53
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	10.56

Financial Position

The company has a current ratio of 8.80, with a Debt / Equity ratio of 0.02.

Current Ratio	8.80
Quick Ratio	8.11
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	0.48
Interest Coverage	-97.41

Financial Efficiency

Return on equity (ROE) is -6.66% and return on invested capital (ROIC) is -25.58%.

Return on Equity (ROE)	-6.66%
Return on Assets (ROA)	-4.18%
Return on Invested Capital (ROIC)	-25.58%
Return on Capital Employed (ROCE)	-7.31%
Weighted Average Cost of Capital (WACC)	11.42%
Revenue Per Employee	$414,296
Profits Per Employee	-$184,935
Employee Count	7,807
Asset Turnover	0.13
Inventory Turnover	3.34

Taxes

In the past 12 months, BioNTech SE has paid $90.74 million in taxes.

Income Tax	90.74M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.96% in the last 52 weeks. The beta is 1.32, so BioNTech SE's price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	-12.96%
50-Day Moving Average	94.23
200-Day Moving Average	99.22
Relative Strength Index (RSI)	50.89
Average Volume (20 Days)	1,083,744

Short Selling Information

The latest short interest is 2.26 million, so 3.30% of the outstanding shares have been sold short.

Short Interest	2.26M
Short Previous Month	2.45M
Short % of Shares Out	3.30%
Short % of Float	n/a
Short Ratio (days to cover)	2.42

Income Statement

In the last 12 months, BioNTech SE had revenue of $3.23 billion and -$1.44 billion in losses. Loss per share was -$5.89.

Revenue	3.23B
Gross Profit	2.54B
Operating Income	-1.63B
Pretax Income	-1.35B
Net Income	-1.44B
EBITDA	-1.37B
EBIT	-1.63B
Loss Per Share	-$5.89

Full Income Statement

Balance Sheet

The company has $15.80 billion in cash and $349.13 million in debt, giving a net cash position of $15.45 billion or $61.11 per share.

Cash & Cash Equivalents	15.80B
Total Debt	349.13M
Net Cash	15.45B
Net Cash Per Share	$61.11
Equity (Book Value)	21.56B
Book Value Per Share	85.25
Working Capital	15.87B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $940.51 million and capital expenditures -$211.00 million, giving a free cash flow of $720.78 million.

Operating Cash Flow	940.51M
Capital Expenditures	-211.00M
Depreciation & Amortization	251.88M
Net Borrowing	-12.19M
Free Cash Flow	720.78M
FCF Per Share	$2.85

Full Cash Flow Statement

Margins

Gross margin is 78.65%, with operating and profit margins of -50.35% and -44.64%.

Gross Margin	78.65%
Operating Margin	-50.35%
Pretax Margin	-41.83%
Profit Margin	-44.64%
EBITDA Margin	-42.47%
EBIT Margin	-50.35%
FCF Margin	22.28%

Dividends & Yields

BioNTech SE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.91%
Shareholder Yield	n/a
Earnings Yield	-6.26%
FCF Yield	3.12%

Dividend Details

Analyst Forecast

The average price target for BioNTech SE is $121.62, which is 34.09% higher than the current price. The consensus rating is "Buy".

Price Target	$121.62
Price Target Difference	34.09%
Analyst Consensus	Buy
Analyst Count	20
Revenue Growth Forecast (3Y)	-4.21%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioNTech SE has an Altman Z-Score of 7.3 and a Piotroski F-Score of 3.

Altman Z-Score	7.3
Piotroski F-Score	3